In a filing, Seres Therapeutics Inc revealed its Chief Legal Officer and EVP DesRosier Thomas unloaded Company’s shares for reported $733.0 on Aug 16 ’24. In the deal valued at $0.84 per share,873 shares were sold. As a result of this transaction, DesRosier Thomas now holds 124,173 shares worth roughly $0.1 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, von Moltke Lisa sold 973 shares, generating $817 in total proceeds. Upon selling the shares at $0.84, the insider now owns 21,013 shares.
Before that, Henn Matthew R. sold 923 shares. Seres Therapeutics Inc shares valued at $775 were divested by the insider at a price of $0.84 per share. As a result of the transaction, Henn Matthew R. now holds 67,247 shares, worth roughly $55142.53999999999.
A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in late April with a ‘”a Neutral”‘ rating. Goldman also remained covering MCRB and has decreased its forecast on July 23, 2021 with a “Sell” recommendation from previously “Neutral” rating.
Price Performance Review of MCRB
On Tuesday, Seres Therapeutics Inc [NASDAQ:MCRB] saw its stock fall -2.44% to $0.82. Over the last five days, the stock has gained 5.73%. Seres Therapeutics Inc shares have fallen nearly -41.75% since the year began. Nevertheless, the stocks have fallen -45.63% over the past one year. While a 52-week high of $2.05 was reached on 01/09/24, a 52-week low of $0.54 was recorded on 04/19/24. SMA at 50 days reached $0.9099, while 200 days put it at $0.9687.
Levels Of Support And Resistance For MCRB Stock
The 24-hour chart illustrates a support level at 0.7975, which if violated will result in even more drops to 0.7794. On the upside, there is a resistance level at 0.8418. A further resistance level may holdings at 0.8680. The Relative Strength Index (RSI) on the 14-day chart is 43.34, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0247, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 69.35%. Stochastics %K at 28.94% indicates the stock is a holding.
How much short interest is there in Seres Therapeutics Inc?
A steep rise in short interest was recorded in Seres Therapeutics Inc stocks on 2024-09-30, growing by 2.72 million shares to a total of 18.66 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 15.94 million shares. There was a rise of 14.56%, which implies that there is a positive sentiment for the stock.
